Past Events
Actinium-225 Spotlight: Nurturing Targeted Alpha Therapy from Production to Patient Care and Beyond
Held virtually in collaboration with Actineer Inc., the CNIC hosted a Scientific Webinar on April 11, 2024, titled “Ac-225 Spotlight: Nurturing TaT from Production to Patient Care and Beyond.” The webinar offered a comprehensive exploration of the emerging radioisotope actinium-225 (Ac-225) and its specific production methods, potential uses in developing radiopharmaceuticals, current supply chain challenges, and revolutionary potential to advance cancer treatment in Targeted Alpha Therapy (TaT).
The Global Nuclear Isotope Landscape: Canada's Role
On February 7th, 2024, The Canadian Nuclear Isotope Council (CNIC) in partnership with the Organization of Canadian Nuclear Industries (OCNI) hosted a webinar titled “The Global Nuclear Isotope Landscape: Canada’s Role.” Led by esteemed leaders in the global and domestic nuclear isotope industry, the panelists took part in an insightful discussion on current developments, emerging challenges, and future opportunities in the medical isotope landscape.